Retinitis pigmentosa (RP) encompasses a set of genetic disorders that gradually impair vision by affecting the retina's photoreceptor cells. Specifically targeting the rod photoreceptors crucial for low-light vision, RP initially manifests as night blindness and progresses to tunnel vision—a narrowing of the visual field—ultimately leading to varying degrees of visual impairment or blindness.
Inherited through autosomal dominant, autosomal recessive, or X-linked recessive patterns, RP's onset and progression vary widely, typically appearing in childhood or adolescence. Despite lacking a cure, ongoing research focuses on potential therapies to slow or halt disease progression. Current management strategies include visual aids, occupational therapy, and genetic counseling to support affected individuals and their families.
Retinitis pigmentosa (RP) is a heterogeneous group of hereditary diseases characterized by progressive degeneration of retinal photoreceptors leading to progressive visual decline. It is the most…
Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.
Oral and poster slots for original Retinitis Pigmentosa work, reviewed by the scientific committee.
Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.
Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.
Plenary lectures from leading voices shaping Retinitis Pigmentosa research and practice.
Attend in person in Singapore or join virtually — same programme, same certificate.
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
The Retinitis Pigmentosa track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Retinitis Pigmentosa. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Retinitis Pigmentosa are all welcome — whether presenting or attending.
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Yes. IOC 2027 is a hybrid conference — attend the Retinitis Pigmentosa track in person in Singapore or join live online, with on-demand access afterward.
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
